193 related articles for article (PubMed ID: 9389376)
1. Chronic neurosteroid treatment prevents the development of morphine tolerance and attenuates abstinence behavior in mice.
Reddy DS; Kulkarni SK
Eur J Pharmacol; 1997 Oct; 337(1):19-25. PubMed ID: 9389376
[TBL] [Abstract][Full Text] [Related]
2. Neurosteroids in nicotine and morphine dependence.
Concas A; Sogliano C; Porcu P; Marra C; Brundu A; Biggio G
Psychopharmacology (Berl); 2006 Jun; 186(3):281-92. PubMed ID: 16133140
[TBL] [Abstract][Full Text] [Related]
3. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
4. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
Shen KF; Crain SM
Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
[TBL] [Abstract][Full Text] [Related]
5. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
[TBL] [Abstract][Full Text] [Related]
6. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
7. Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice.
Reddy DS; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1997; 19(6):395-405. PubMed ID: 9385589
[TBL] [Abstract][Full Text] [Related]
8. Tianeptine reduces morphine antinociceptive tolerance and physical dependence.
Chu CC; Shieh JP; Shui HA; Chen JY; Hsing CH; Tzeng JI; Wang JJ; Ho ST
Behav Pharmacol; 2010 Sep; 21(5-6):523-9. PubMed ID: 20679893
[TBL] [Abstract][Full Text] [Related]
9. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
10. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
Cichewicz DL; Welch SP
J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
[TBL] [Abstract][Full Text] [Related]
11. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
[TBL] [Abstract][Full Text] [Related]
12. The role of GABA-A and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice.
Reddy DS; Kulkarni SK
Psychopharmacology (Berl); 1998 Jun; 137(4):391-400. PubMed ID: 9676900
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic administration of calcium-magnesium soft gels on morphine tolerance and dependence in mice.
Khajehali E; Sadeghi HM; Rabbani M
Magnes Res; 2009 Jun; 22(2):81-8. PubMed ID: 19658277
[TBL] [Abstract][Full Text] [Related]
14. Obestatin prevents analgesic tolerance to morphine and reverses the effects of mild morphine withdrawal in mice.
Lipták N; Dochnal R; Csabafi K; Szakács J; Szabó G
Regul Pept; 2013 Sep; 186():77-82. PubMed ID: 23891980
[TBL] [Abstract][Full Text] [Related]
15. Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal.
McLane VD; Bergquist I; Cormier J; Barlow DJ; Houseknecht KL; Bilsky EJ; Cao L
Life Sci; 2017 Sep; 185():1-7. PubMed ID: 28723417
[TBL] [Abstract][Full Text] [Related]
16. Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence.
Lutfy K; Parikh D; Lee DL; Liu Y; Ferrini MG; Hamid A; Friedman TC
Neuroscience; 2016 Aug; 329():318-25. PubMed ID: 27208618
[TBL] [Abstract][Full Text] [Related]
17. Diazepam pretreatment suppresses morphine withdrawal signs in the mouse.
Suzuki T; Tsuda M; Narita M; Funada M; Mizoguchi H; Misawa M
Life Sci; 1996; 58(4):349-57. PubMed ID: 8538371
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive potentiation and attenuation of tolerance by intrathecal electric stimulation in rats.
Lin CR; Yang LC; You HL; Lee CT; Tai MH; Tan PH; Lin MW; Cheng JT
Anesth Analg; 2003 Jun; 96(6):1711-1716. PubMed ID: 12761002
[TBL] [Abstract][Full Text] [Related]
19. Effects of calcitonin gene-related peptide on acute and chronic effects of morphine.
Azarov AV; Szabó G; Czakó L; Telegdy G
Pharmacol Biochem Behav; 1995 Nov; 52(3):595-9. PubMed ID: 8545480
[TBL] [Abstract][Full Text] [Related]
20. Influence of prazosin and clonidine on morphine analgesia, tolerance and withdrawal in mice.
Ozdoğan UK; Lähdesmäki J; Scheinin M
Eur J Pharmacol; 2003 Jan; 460(2-3):127-34. PubMed ID: 12559372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]